Jennifer R. Bellon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jennifer R. Bellon has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
Julia S. Wong
Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women׳s Hospital, Boston, MA
4 shared publicationsJay R. Harris
3 shared publicationsLinh Truong
Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA
3 shared publicationsPaul J. Catalano
Department of Biostatistics, Harvard T. H. Chan School of Public Health, and Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA
3 shared publicationsRinaa S. Punglia
Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts
3 shared publications- Yulia Lyatskaya
Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, Massachusetts
3 shared publications
Latest Publications
- 1 July 2019
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 104 (4) , 867-868
Defining the Optimal Schedule for External Beam Partial Breast Irradiation
- 1 July 2019
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 104 (4) , 867-868
Defining the Optimal Schedule for External Beam Partial Breast Irradiation
- 14 March 2017
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 109 (8)
Editorial: Regional Nodal Irradiation in the Anti-HER2 Era
Regional nodal irradiation (RNI) in women with node-positive and high-risk node-negative breast cancer has long been controversial. The rate of clinically evident recurrence in either the supraclavicular (SCV) or internal mammary (IM) region among women with one to three involved axillary nodes is low (1), but nodal recurrence may not be the best metric for evaluating the benefit of RNI. Adding to the controversy is the inclusion of comprehensive nodal treatment in most randomized trials of postmastectomy radiation, a meta-analysis of which demonstrated a survival benefit (2). The question of nodal treatment was recently brought to the forefront by two randomized trials of RNI, both of which showed an improvement in disease-free survival (DFS). The NCIC MA.20 trial (3) randomly assigned 1832 women, all of whom had...
- 14 March 2017
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 109 (8)
Editorial: Regional Nodal Irradiation in the Anti-HER2 Era
Regional nodal irradiation (RNI) in women with node-positive and high-risk node-negative breast cancer has long been controversial. The rate of clinically evident recurrence in either the supraclavicular (SCV) or internal mammary (IM) region among women with one to three involved axillary nodes is low (1), but nodal recurrence may not be the best metric for evaluating the benefit of RNI. Adding to the controversy is the inclusion of comprehensive nodal treatment in most randomized trials of postmastectomy radiation, a meta-analysis of which demonstrated a survival benefit (2). The question of nodal treatment was recently brought to the forefront by two randomized trials of RNI, both of which showed an improvement in disease-free survival (DFS). The NCIC MA.20 trial (3) randomly assigned 1832 women, all of whom had...
- 22 July 2016
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 23 (12) , 3870-3879
Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer
Higher body mass index (BMI) has been associated with increased distant recurrence and decreased survival for women with breast cancer. However, the relationship between BMI and locoregional recurrence (LRR) has been less well studied and was therefore the subject of this investigation. The study identified 878 women with early-stage invasive breast cancer who underwent breast-conservation therapy (BCT) between June 1997 and October 2007. Time from diagnosis to LRR was calculated using a competing risk analysis with contralateral breast cancer (CBC), distant metastases (DM), and death as the competing risks. Gray's competing risks analysis, which included an interaction term between menopausal status and BMI, was used to identify significant risk factors for the development of LRR. After a median follow-up period of 10.8 years, LRR was diagnosed as a first event for 45 women. In a multivariable analysis, BMI was positively associated with LRR but only in premenopausal women. Specifically, when these women were compared with normal- and underweight women, both the overweight women (hazard ratio (HR), 2.97; 95 % confidence interval (CI) 1.04-8.46; p = 0.04) and the obese women (HR, 3.36; 95 % CI 1.07-10.63; p = 0.04) showed a higher risk of LRR. A similar association between BMI and disease-free survival was noted for premenopausal but not postmenopausal women. For premenopausal women with invasive breast cancer who undergo BCT, BMI is an independent prognostic factor for LRR. If confirmed, these findings suggest that more aggressive treatment strategies may be warranted for these women.
- 22 July 2016
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 23 (12) , 3870-3879
Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer
Higher body mass index (BMI) has been associated with increased distant recurrence and decreased survival for women with breast cancer. However, the relationship between BMI and locoregional recurrence (LRR) has been less well studied and was therefore the subject of this investigation. The study identified 878 women with early-stage invasive breast cancer who underwent breast-conservation therapy (BCT) between June 1997 and October 2007. Time from diagnosis to LRR was calculated using a competing risk analysis with contralateral breast cancer (CBC), distant metastases (DM), and death as the competing risks. Gray's competing risks analysis, which included an interaction term between menopausal status and BMI, was used to identify significant risk factors for the development of LRR. After a median follow-up period of 10.8 years, LRR was diagnosed as a first event for 45 women. In a multivariable analysis, BMI was positively associated with LRR but only in premenopausal women. Specifically, when these women were compared with normal- and underweight women, both the overweight women (hazard ratio (HR), 2.97; 95 % confidence interval (CI) 1.04-8.46; p = 0.04) and the obese women (HR, 3.36; 95 % CI 1.07-10.63; p = 0.04) showed a higher risk of LRR. A similar association between BMI and disease-free survival was noted for premenopausal but not postmenopausal women. For premenopausal women with invasive breast cancer who undergo BCT, BMI is an independent prognostic factor for LRR. If confirmed, these findings suggest that more aggressive treatment strategies may be warranted for these women.
- 1 January 2016
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 26 (1) , 37-44
Management of the Regional Lymph Nodes in Early-Stage Breast Cancer
- 1 January 2016
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 26 (1) , 37-44
Management of the Regional Lymph Nodes in Early-Stage Breast Cancer
- 20 December 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (36) , 4314
Reply to A. Fiorentino et al
- 20 December 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (36) , 4314
Reply to A. Fiorentino et al
- 1 December 2015
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 93 (5) , 1087-1095
Dosimetric Inhomogeneity Predicts for Long-Term Breast Pain After Breast-Conserving Therapy
- 1 December 2015
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 93 (5) , 1087-1095
Dosimetric Inhomogeneity Predicts for Long-Term Breast Pain After Breast-Conserving Therapy
- 1 November 2015
- Published by Elsevier in Practical Radiation Oncology
- Vol. 5 (6) , 358-365
Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancer
- 1 November 2015
- Published by Elsevier in Practical Radiation Oncology
- Vol. 5 (6) , 358-365
Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancer
- 1 October 2015
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 1 (7) , 941-2
Hypofractionation for Early-Stage Breast Cancer: No More Excuses.
- 1 October 2015
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 1 (7) , 941-2
Hypofractionation for Early-Stage Breast Cancer: No More Excuses.
- 23 July 2015
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (10) , 3213-3218
Controversies in Radiation Oncology for Early-Stage Breast Cancer
- 23 July 2015
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (10) , 3213-3218
Controversies in Radiation Oncology for Early-Stage Breast Cancer
- 20 June 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (18) , 1998-2000
Personalized Radiation Oncology for Breast Cancer: The New Frontier
- 20 June 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (18) , 1998-2000
Personalized Radiation Oncology for Breast Cancer: The New Frontier